

NCT00728156 comparison:

Summary:
CHIA has 16 criteria while your personal folder has 16 criteria
Total found criteria: 16/16
Total not Found: 0/16
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤═══════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                        │
╞════════════════════════════════════════════════════╪═══════════════════════════════════════════════════╡
│ Patients with T2DM and CAS as defined below        │ Patients with T2DM and CAS as defined below       │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Clinical definitions                               │ Clinical definitions                              │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ T2DM: Diagnosed according to the WHO criteria [53] │ T2DM: Diagnosed according to the WHO criteria     │
│                                                    │ \[53\]                                            │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ CAD:Presence of any one of the following: Angina   │ CAD:Presence of any one of the following: Angina  │
│ plus positive exercise tolerance test, enzyme      │ plus positive exercise tolerance test, enzyme     │
│ and/or Q wave positive myocardial infarction,      │ and/or Q wave positive myocardial infarction,     │
│ angiographic evidence ( >50% stenosis of one       │ angiographic evidence ( \>50% stenosis of one     │
│ vessel), percutaneous or surgical coronary         │ vessel), percutaneous or surgical coronary        │
│ revascularisation                                  │ revascularisation                                 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Aged between 18 and 75                             │ Aged between 18 and 75                            │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Provided written consent for participation in the  │ Provided written consent for participation in the │
│ trial prior to any study-specific procedures or    │ trial prior to any study-specific procedures or   │
│ requirements                                       │ requirements                                      │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Contraindication to Clopidogrel                    │ Contraindication to Clopidogrel                   │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Smoking (current smokers and patients who quit     │ Smoking (current smokers and patients who quit    │
│ smoking less than six months)                      │ smoking less than six months)                     │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Malignancy(diagnosed or under investigation)       │ Malignancy(diagnosed or under investigation)      │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Haematological disorders (Anaemia, malignancy,     │ Haematological disorders (Anaemia, malignancy,    │
│ bleeding disorders)                                │ bleeding disorders)                               │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Women of child-bearing potential                   │ Women of child-bearing potential                  │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Use of corticosteroids/other antithrombotic        │ Use of corticosteroids/other antithrombotic       │
│ agents(warfarin)                                   │ agents(warfarin)                                  │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Chronic liver disease (Cirrhosis, malignancy and   │ Chronic liver disease (Cirrhosis, malignancy and  │
│ patients with more than twice the upper limit of   │ patients with more than twice the upper limit of  │
│ liver function tests)                              │ liver function tests)                             │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Unable to consent                                  │ Unable to consent                                 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Use of other investigational study drugs within 1  │ Use of other investigational study drugs within 1 │
│ year prior to study entry                          │ year prior to study entry                         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Previous participation in this study               │ Previous participation in this study              │
╘════════════════════════════════════════════════════╧═══════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
├───────────────────────────────────┤
│ Must have maximum age of 75 Years │
╘═══════════════════════════════════╛